Amneal Pharmaceuticals (AMRX) PT Raised to $25 at UBS on Near Term Growth Drivers

August 3, 2026 8:50 AM

(Updated - August 3, 2026 10:05 AM EDT)

UBS analyst Ashwani Verma raised the price target on Amneal Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found